A New Approach to Purpose-Built Linux With the global embedded systems market expected to grow at a CAGR of 5.5% by 2026, it’s never been more important for developers to rethink their approach to edge solutions. Enter Wind River®—with insights into leveraging purpose-built Linux for the intelligent edge. In this on-demand webinar, you will hear fr
Read More
EPP (Endpoint Protection for Business): Buyer’s Guide & Reviews, February 2024
EPP (Endpoint Protection for Business): Buyer’s Guide & Reviews, February 2024 Businesses around the world are looking to invest in a top-quality endpoint protection for business (EPP) solution to safeguard the endpoints of their distributed workforce. But in such a crowded market, how do you identify the best solution for your specific
Read More
Endpoint Compliance: Buyer’s Guide & Reviews, March 2024
Endpoint Compliance: Buyer’s Guide & Reviews, March 2024 Endpoint compliance serves as a crucial protective measure against serious cybersecurity risks. That’s why CyberArk recommends building a thoughtful strategy for endpoint conformity. Your forward-thinking peers increasingly rely on PeerSpot’s insights to inform their in
Read More
Cue Biopharma & Benchling: Evolving into a clinical-stage organization
Cue Biopharma & Benchling: Evolving into a clinical-stage organization n the fast-paced world of biopharma, efficient data management is crucial for driving safe and effective immunotherapies. So, when Cue Biopharma faced challenges with non-standard data capture and collaboration between teams, they turned to Benchling for help. In this case
Read More
From the bench to the clinic: The rapidly changing expectations of process development
From the bench to the clinic: The rapidly changing expectations of process development As process development teams strive to move innovations from early discovery into the clinic and manufacturing—issues regarding volume, speed, and complexity emerge to hinder progress. To thrive in today’s volatile biotechnology landscape, Benchling recommends ev
Read More
Essential digital capabilities for modern process development
Essential digital capabilities for modern process development Process development teams in biotechnology increasingly strive to accelerate market access and create innovative treatments. As a result, expertise in digital strategy and data management emerged as an imperative. Read this comprehensive guide to gain an in-depth view of the transformati
Read More
The Path To AI-powered Retail – The Retail Data Strategy You Need Now To Support The AI Future
eBook: The Path To AI-powered Retail – The Retail Data Strategy You Need Now To Support The AI Future If you’re like 98% of executives out there, you believe that AI (artificial intelligence) models will play an important role in your business strategy in the next three to five years.1 The challenge for many retailers, however, […]
Read More
Smarter observability with AIOps, generative AI, and machine learning
Smarter observability with AIOps, generative AI, and machine learning The impact of cloud-native technologies has created challenges around managing the volume, complexity, and pace of change in applications for SREs and operations teams. The emergence of AIOps to help deal with this complexity is a real solution to these real challenges. Take a to
Read More
Getting started with APM and distributed tracing on Elastic Observability
ON-DEMAND WEBINAR Getting started with APM and distributed tracing on Elastic Observability Hosted by: Luca WintergerstProduct MarketingDirectorElastic Overview Learn how to deploy APM and distributed tracing on Elastic Observability! We’ll show you why APM deployed on top of your existing logs and metrics are crucial to truly understanding h
Read More
State of Tech in Biopharma Report
State of Tech in Biopharma Report As biopharma races toward delivering medicines faster, it’s adopting cloud tech, AI / ML, and robotics to improve R&D productivity. This report surveys over 300 biopharma experts — across R&D and IT functions — to understand usage, impact, and challenges biopharma faces in adoption. Respondent demographics
Read More